Trials / Completed
CompletedNCT02032407
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the effect of dapsone gel in female subjects with skin of color (Fitzpatrick Skin Types IV, V, and VI) with acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dapsone Gel | Dapsone Gel (Aczone®) applied twice daily to the face for 12 weeks. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-06-01
- Completion
- 2014-09-01
- First posted
- 2014-01-10
- Last updated
- 2015-08-19
- Results posted
- 2015-08-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02032407. Inclusion in this directory is not an endorsement.